COSA 2016November 15 - 17, 2016 Gold Coast Convention and Exhibition Centre

Dr Alex Menzies

Dr Alex Menzies is a Medical Oncologist and Senior Research Fellow at Melanoma Institute Australia, Royal North Shore Hospital and The University of Sydney in Sydney, Australia. He completed specialist oncology training in 2011 and received his PhD from The University of Sydney in 2014 for research exploring the biology of BRAF-mutant melanoma and biomarkers of response and resistance to targeted therapy. Since 2009 he has been an investigator on over 30 Phase I to III clinical trials of targeted therapies and immunotherapies in melanoma, including the Phase I trials of dabrafenib, combination dabrafenib and trametinib, pembrolizumab and combination ipilimumab and pembrolizumab. He has published several original research and review articles in melanoma, and is a regular invited speaker at national and international meetings. His main research interests are the biology of melanoma and biomarkers of response and resistance to systemic therapy.